X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (633) 633
female (486) 486
male (485) 485
hematology (475) 475
index medicus (438) 438
transplantation (415) 415
adult (404) 404
myeloablative agonists - administration & dosage (394) 394
middle aged (381) 381
immunology (298) 298
transplantation conditioning - methods (273) 273
adolescent (253) 253
oncology (235) 235
aged (230) 230
bone-marrow-transplantation (226) 226
transplantation, homologous (226) 226
myeloablative agonists - therapeutic use (218) 218
hematopoietic stem cells (202) 202
stem cells (199) 199
hematopoietic stem cell transplantation (178) 178
child (170) 170
myeloablative agonists - adverse effects (170) 170
retrospective studies (169) 169
vidarabine - analogs & derivatives (168) 168
busulfan - administration & dosage (166) 166
treatment outcome (166) 166
hematology, oncology and palliative medicine (162) 162
transplantation conditioning (157) 157
disease-free survival (153) 153
child, preschool (142) 142
stem-cell transplantation (142) 142
versus-host-disease (133) 133
melphalan - administration & dosage (132) 132
vidarabine - administration & dosage (131) 131
chemotherapy (125) 125
young adult (123) 123
hematopoietic stem cell transplantation - methods (118) 118
cyclophosphamide (117) 117
hematopoietic stem cell transplantation - adverse effects (112) 112
survival analysis (112) 112
transplantation, autologous (110) 110
health aspects (109) 109
care and treatment (108) 108
graft vs host disease - prevention & control (108) 108
busulfan (105) 105
cyclophosphamide - administration & dosage (104) 104
transplantation conditioning - adverse effects (103) 103
infant (102) 102
survival rate (102) 102
risk factors (97) 97
follow-up studies (96) 96
cancer (95) 95
dosage and administration (95) 95
bone marrow (93) 93
analysis (91) 91
fludarabine (91) 91
hematologic neoplasms - therapy (87) 87
therapy (87) 87
mortality (86) 86
recurrence (82) 82
stem cell transplantation (80) 80
leukemia (77) 77
research (77) 77
graft vs host disease - mortality (74) 74
article (72) 72
melphalan (72) 72
children (69) 69
prospective studies (65) 65
remission induction (65) 65
acute myeloid-leukemia (64) 64
graft vs host disease - etiology (64) 64
total-body irradiation (64) 64
busulfan - adverse effects (63) 63
combined modality therapy (63) 63
immunosuppressive agents - administration & dosage (61) 61
multiple myeloma - therapy (58) 58
time factors (57) 57
multiple myeloma (56) 56
whole-body irradiation (55) 55
unrelated donors (54) 54
animals (53) 53
bone marrow transplantation (53) 53
pharmacokinetics (53) 53
antineoplastic combined chemotherapy protocols - therapeutic use (52) 52
patient outcomes (52) 52
survival (51) 51
drug administration schedule (50) 50
pediatrics (50) 50
busulfan - pharmacokinetics (48) 48
conditioning regimen (48) 48
hematologic neoplasms - mortality (48) 48
hematopoietic stem cell transplantation - mortality (48) 48
acute disease (47) 47
prognosis (47) 47
graft survival (46) 46
leukemia, myeloid, acute - therapy (46) 46
melphalan - adverse effects (46) 46
myeloablative agonists - pharmacokinetics (46) 46
immunosuppressive agents - therapeutic use (43) 43
toxicity (43) 43
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (650) 650
French (3) 3
Chinese (2) 2
German (2) 2
Russian (2) 2
Danish (1) 1
Hungarian (1) 1
Japanese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 117 - 122
Abstract Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by... 
Hematology, Oncology and Palliative Medicine | Haploidentical transplantations | Acute leukemia | HLA | Posttransplantation cyclophosphamide | Allogeneic stem cell transplant | MORTALITY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | TRANSPLANTATION | REDUCED-INTENSITY | ACUTE-LEUKEMIA | HIGH-RISK | HAPLOTYPE | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | BLOOD | Hematologic Neoplasms - therapy | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Follow-Up Studies | Myeloablative Agonists - adverse effects | Thiotepa - administration & dosage | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Graft vs Host Disease - mortality | Antineoplastic Agents - adverse effects | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Acute Disease | Busulfan - adverse effects | Vidarabine - adverse effects | Survival Rate | Vidarabine - analogs & derivatives | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Vidarabine - administration & dosage | Transplantation Conditioning | Chronic Disease | Thiotepa - adverse effects | Antimitotic agents | Pneumonia | Cyclophosphamide | Bacterial pneumonia | Mortality | Bone marrow | Transplantation | Antineoplastic agents | Cancer
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2008, Volume 26, Issue 32, pp. 5233 - 5239
Journal Article
Blood, ISSN 0006-4971, 06/2008, Volume 111, Issue 12, pp. 5530 - 5536
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2012, Volume 48, Issue 16, pp. 3063 - 3072
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 30, pp. 4630 - 4634
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2007, Volume 357, Issue 11, pp. 1083 - 1093
Journal Article
Journal Article
Blood, ISSN 0006-4971, 01/2009, Volume 113, Issue 5, pp. 995 - 1001
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 5/2012, Volume 51, Issue 5, pp. 331 - 345
Journal Article
Journal Article